Background: Diclofenac Sodium (DCL) and Moxifloxacin HCl (MOX) were simultaneously used after cataract surgery to reduce the post-operative inflammation and to control infection respectively. Objectives: Three simple, accurate, eco-friendly and reproducible UV spectroscopic methods were established for concurrent determination of diclofenac sodium and moxifloxacin in ophthalmic preparation without prior separation. Methods:
INTRODUCTION
Cataract surgery has become more common in old age population both in rural and urban area. 1 To avoid the post-operative cataract complications different topical preparations have been used, such as anti-inflammatory agents, antibiotics and anti-glaucoma preparations. To control the post-operative inflammation and to reduce the edema Non-steroidal anti-inflammatory drugs (NSAIDs) were preferred over steroidal preparation due to the safety. 2 Further NSAIDs have similar efficacy as corticosteroids in controlling the pain, inflammation and formation of the blood-aqueous barrier after the cataract surgery. 2, 3 Several NSAIDs ophthalmic preparations are available in the market, however, diclofenac sodium (DCL Figure 1A) preparation is most widely prescribed to control post-operative pain and inflammation. 4 DCL act by inhibition of Cyclooxygenase (COX) enzyme thereby inhibiting the formation of prostaglandins, thereby reduce the pain and inflammation Topical antibiotics are also applied after the cataract surgery as a prophylaxis to avoid post-operative infection. The fourth-generation fluoroquinolones, such as moxifloxacin HCl (MOX Figure 1B ) has been preferred due to its broad-spectrum activity against Gram-positive and Gram-negative micro-organisms. Moxifloxacin acts as a bactericidal by inhibiting bacterial DNA gyrase and topoisomerase-4. [5] [6] [7] Hence, diclofenac sodium and moxifloxacin ophthalmic solutions are used simultaneously after the cataract surgery. Several analytical methods such as spectrophotometry, [8] [9] [10] [11] [12] RP-HPLC [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and electroanalytical methods [24] [25] [26] were reported in the literature for the quantification of DCL and MOX alone or with other drugs. However, the simultaneous determination of DCL and MOX has not been reported.
The objective of the current study was to establish a simple, economical, eco-friendly and precise derivative spectrophotometric procedure for concurrent estimation of DCL and MOX from laboratory mixed ophthalmic preparations.
MATERIALS AND METHODS
Pure samples of moxifloxacin (99.4%) and diclofenac sodium (99.5%) were purchased from the Sigma Aldrich (Germany), Moxifloxacin (0.5%) and diclofenac sodium (0.1%) ophthalmic preparations were procured from the local market. Methanol used to prepare primary standard stock solution was obtained from Sigma Aldrich (Germany). Distilled water prepared by Milli Q (Millipore, USA) water purifier was used throughout the experiments. Shimadzu UV-Vis spectrophotometer (1700) with 10 mm quartz cuvettes were used to record the UV absorption spectra. Absorption of solutions was measured at medium speed with a sampling interval of 0.1 nm. The instrument has a fixed slit width of 1 nm. Manipulation of absorption spectra and measurement of amplitude were carried out with the help of Shimadzu UV-probe (Version 2) software.
Stock solutions of DCL and MOX
Standard stock solutions of DCL and MOX were arranged by precisely weighed 100 mg each and transferred into 10 mL measuring flask separately. Both the analytes were dissolved in methanol and the final volume was adjusted with methanol and stored in a refrigerator. Further, the working standard and laboratory mixed solutions were prepared by diluting stock solutions with water. Stock solutions were stable for two weeks in the refrigerator and working standard solutions were prepared daily.
Procedure for construction of calibration curve
Required amount of standard solutions of DCL and MOX were transferred into the 10 mL volumetric flasks to get the six solutions in the concentration range of 1-15 µg/mL of DCL and 1-18 µg/mL MOX separately. All these solutions were scanned in the range of 200 -400 nm against water as blank and spectra were stored in the computer. Further, for the first derivative spectroscopic method, spectra were converted into first derivative spectra using 4nm as ∆λ with scaling factor 10. The peak amplitude was measured at 216.2 nm, the zero crossings for MOX, for quantification of DCL and similarly, the peak amplitude was measured at 276.1 nm, the zero crossings for DCL, for quantification of MOX. Further, the calibration curves were created for both analytes by plotting a graph between peak amplitude against corresponding concentrations. In addition, regression equations were figured. For ratio difference spectroscopic technique previously saved zero-order spectra of DCL (1-15 µg/mL) were divided by UV absorption spectrum of MOX (4 µg/mL) to get ratio spectra. Then the peak amplitude was measured at 338.6 nm and 303.7 nm. The difference between these two amplitudes were calculated and the calibration curve was construed against the corresponding concentration of DCL. Similarly, zero-order spectra of MOX (1 -18 µg/mL) were divided by UV absorption spectrum of DCL (3 µg/mL) to get ratio spectra. Difference between the amplitudes at 265.5 nm and 246.2 nm was determined and the calibration curve was constructed against the corresponding concentration of MOX. Alternatively, regression equations were computed and used for the determination of the concentration of formulation and other solutions. For ratio first derivative spectroscopic method, ratio spectra of DCL (1 -15 µg/mL) were converted into first derivative spectra using 4 nm as ∆λ with scaling factor 1 nm. The peak amplitude was measured at 259.0 nm and calibration curve was constructed against corresponding concentration. Similarly, ratio spectra of MOX (1 -18 µg/mL) were converted into the first derivative spectra using 4 nm as ∆λ with scaling factor 1. Further, peak amplitude was measured at 333.6 nm and the calibration curve was constructed.
Procedure for assay of laboratory prepared solutions
Aliquot of standard solutions of DCL and MOX were transferred into 10 mL measuring flasks to get different ratio of both the analytes 1:5, 1:10, 1:18, 9:5, 9:10, 9:18, 15:5, 15:10, 15:18 µg/mL respectively. Then the solutions were diluted with distilled water, absorption spectra were recorded and stored. Further, to determine the concentration of DCL and MOX from the mixture, spectra were converted into the first derivative, ratio spectra and the first derivative of ratio spectra according to the above-stated procedure. Further, peak amplitudes were measured at the respective wavelengths and concentration were determined using the relevant calibration curve or regression equations.
Procedure for assay of sample solutions
The sample solution was prepared by accurately transferring DCL and MOX ophthalmic solutions (1 mL each) into 10 mL measuring flask. Then five mL methanol was added and the final volume was made with distilled water. Further, this solution was diluted with water to get the amount of DCL and MOX in the range of calibration curve. The sample solution was scanned in the range of 200 nm-400 nm and converted into the first derivative, ratio spectra and the first derivative of ratio spectra according to the above-mentioned procedure. Further concentration of DCL and MOX was determined from the calibration curves by all the methods.
RESULTS AND DISCUSSION
The over laid UV absorption spectra of DCL and MOX showed the complete overlap of spectra, ( Figure  2 ) making it difficult to estimate simultaneously without prior separation. However, derivatization of spectra and measuring the peak amplitude at zero crossings of one of the analyte allow the quantification of one analyte in presence of another and formulation excipients a possible interfering components [27] [28] [29] (Figure 3 ). Derivatization is a simple process, reliable, reproducible and shows good resolution of analytes from each other. Further, it reduces the signal to noise ratio and the use of scaling factor increases the sensitivity of the method.
In our study, a series of DCL and MOX solutions were converted into first derivative spectra separately ( Figure 4A and 4B). Different wavelengths 2, 4, 6, 8 nm as ∆λ and different scaling factor from 10 to 100 were tried, however, 4 nm as ∆λ and scaling factor of 10 showed good resolution of analytes and appropriate signal to noise ratio. Hence all spectra were converted using 4 nm as ∆λ and scaling factor of 10. The binary mixture of DCL and MOX was analyzed by measuring the peak amplitude at 216.6 nm for DCL, a zero-crossing point for MOX and at 276.1 nm for MOX, a zero crossing for DCL ( Figure 3 ). The second method was based on the amplitude difference between two wavelengths of ratio spectra, which eliminate the interference of another analyte. Generally, determine the one component in the presence of another. Advantages of ratio derivative spectra are need not look for zero-crossing points and also give many maxima and minima to measure the amplitude, which is proportional to only one analyte. In our study, the above-generated ratio spectra of DCL were converted into the first derivative spectra using 4 nm as ∆λ with scaling factor 1. First derivative spectra of DCL ( Figure 6C ) showed one maximum at 259.0 nm and 4 minima at 313.4, 273.1, 227.7 and 210.2 nm. However, peak amplitude and recovery percentage were better at 259.0 nm compared to other wavelengths. Similarly, the first derivative spectra of MOX were generated from the above-recorded ratio spectra of MOX (1 -18 µg/mL) using 4 nm as ∆λ with scaling factor 1. First derivative spectra ( Figure 6D) 
Validation of methods
The proposed approaches were validated for linearity, sensitivity, selectivity, stability, accuracy and precision as per the requirements of ICH, to prove that the proposed methods can be used for the intended purpose.
Linearity
The linearity of the suggested procedures was established by evaluating the six samples in the concentration range of 1-15 µg/mL for DCL and 1-18 µg/mL for two wavelengths selected were corresponding to the peak and the trough, to get maximum sensitivity. It is clear from the Figure 5A and 5B that the peak to trough difference of ratio spectra generated from the binary mixture and standard pure analyte remains same for the same amount of analyte, hence, the amplitude obtained by taking the difference between two selected wavelength is directly proportional to the concentration of the one analyte, without the interference from another. In our work, spectra of DCL in a range of 1-15 µg/mL were divided by the spectra of MOX (4 µg/mL) to generate ratio spectra of DCL ( Figure 6A ). Amplitude difference for DCL was determined by subtracting the trough amplitude at 303.7 nm from peak amplitude at 338.6 nm and plotted against the concentration of DCL to generate the calibration curve along with the regression equation. Similarly, a series of MOX spectra in the range of 1 -18 µg/mL were converted into ratio spectra ( Figure  6B ) by dividing with DCL spectra (3 µg/mL). The two wavelengths selected were 265.5 nm of peak and 246.2 nm of a trough, the amplitude difference between these wavelengths was plotted against the concentration of MOX to generate the calibration curve along with the regression equation.
The third method was the first derivative of ratio spectra, an alternative to the amplitude difference. According to the Salinas proposal, 29 the conversation of ratio spectra into derivative spectra will eliminate the interference from one of the analytes, allowing to MOX and (B) MOX (1, 4, 8, 12, 16 and 18 µg/mL) using 3 µg/mL DCL. MOX. For all the three methods amplitude determined were plotted against corresponding concentration to generate the calibration curves ( Figure 7 ) along with regression equations. Table 1 , showed results of regression equations for both the analytes by all the three methods. It is evident from the correlation coefficient (r 2 ≈1) that proposed analytical methods showed good linearity for both analytes. Further, the standard deviation of a slope, intercept and residuals were found to be low, confirming the good linearity of the methods.
Figure 7: Calibration curves for First derivative method DCL (Ia) and MOX (IIc). Ratio difference Method DCL (Ib) and MOX (III) First derivative of Ratio method DCL (IId) and MOX (IV).

Sensitivity
Limit of detection and limit of quantification were calculated to confirm the sensitivity of the method. LOD was determined by multiplying 3.3 with the ratio of the standard deviation of intercept to the slope of the calibration curve. LOQ was determined by multiplying 10 with the ratio of the standard deviation of intercept to the slope of the calibration curve. The low LOD and LOQ showed in Table 1 indicated the good sensitivity of the proposed methods.
Precision and accuracy
Intra-day and inter-day accuracy and precision were determined by evaluating both analytes at three different concentration (low, medium and high) covering the entire calibration range. For intra-day, all these solutions were analyzed by proposed methods on the same day in triplicate (n=3). For inter-day, same solutions were analyzed on three successive days in triplicate (n=9).
The precision was expressed as %RSD ( Table 2) and was found to less than 2, indicating good precision of the procedures. Accuracy was expressed as the percentage relative error (%RE). The low %RE indicated the accuracy of the suggested procedures.
Recovery studies
Recovery studies were executed at three diverse levels (50%, 100% and 150%) to confirm the specificity and accuracy of the anticipated approaches by the standard addition method. To the previously analyzed formulation consisting of 1 µg/mL of DCL and 5 µg/mL, of MOX, 0.5, 1.0, 1.5 µg/mL of DCL and 2.5, 5, 7.5 µg/mL of MOX were added separately. All these solutions were analyzed by proposed methods and peak amplitudes were determined. The concentration of the added amount of DCL and MOX were calculated using the regression equation and subtraction of initial formulation concentration. The good recovery of DCL and MOX from the formulation with low %RSD (Table 3) confirmed the specificity and accuracy of the suggested approaches. Indicating the absence of interference from the formulation excipients during the analysis.
Stability of solutions
Stock solutions were stored in the refrigerator at 4°C and working standard solutions were prepared on a daily basis. Stock solutions in methanol and working solutions prepared in water were analyzed spectrophotometrically after storing at room temperate for five hours. Solutions did not show a significant difference in the assay results even after 15 days.
Application of proposed methods
Assay of laboratory prepared solutions
To study the applicability of the suggested procedures for the concurrent quantification of DCL and MOX, laboratory prepared solutions were analyzed. Different ratio of binary mixture DCL and MOX covering both above and below the normal level were prepared and analyzed by proposed methods. The good percent recovery and low %RSD and %RE error results (Table 4) , indicated the excellent accuracy and precision of the methods and their power to analyze simultaneously DCL and MOX without prior separation, present even in different ratios. 
Application to a real pharmaceutical preparation
Proposed spectroscopic procedures were utilized for simultaneous quantification of DCL and MOX from ophthalmic preparation mixture. The results were tabulated in Table 5 , in comparison with the reported HPLC method. The recovery results were inconsistent with the labeled amount, with low %RSD, indicating the suitability of the suggested procedures for regular quality control of both DCL and MOX ophthalmic preparations.
The statistical comparison of proposed and reported method showed low "t" and 'F" value. Indicating no significant difference in the assay results of both methods in terms of accuracy and precision.
CONCLUSION
A simple, accurate and reproducible UV spectroscopic methods were established for concurrent quantification of DCL and MOX without the use of any sophisticated instrument or software. Water has been used as a solvent, making these methods economical and ecofriendly. Analysis of laboratory prepared mixture confirmed the accuracy, specificity and also absence of interference from formulation excipients. Further, statistical comparison with reported HPLC methods exhibited no statistical difference between the outcomes of proposed and reported methods in terms of accuracy and precision. 
SUMMARY
The objective of the current work was to develop a simple, economical and eco-friendly UV spectroscopic methods for simultaneous determination of diclofenac sodium and moxifloxacin from eye drops. Three different spectroscopic methods were established by manipulation of UV spectra. The first technique was established on the measurement of a peak amplitude of the first derivative spectra at the zero-crossing wavelength of one analyte. The second method was the determination of peak amplitude difference between peak and trough of ratio spectra. The third method involves the measurement of the peak amplitude of the first derivative of ratio spectra. Water has been used as a solvent. All three methods were validated according to the ICH guidelines. Further, proposed methods were efficiently applied for the simultaneous estimation of both analyses from ophthalmic preparations. 
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